Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres. - Wikidata - wikimedia - TriplyDB

Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

http://www.wikidata.org/entity/Q41990628

about

Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.Formulation and Evaluation of Propranolol Hydrochloride-Loaded Carbopol-934P/Ethyl Cellulose Mucoadhesive Microspheres.Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation.Development and evaluation of sustained-release etoposide-loaded poly(ε-caprolactone) implants.Ethylcellulose-based matrix-type microspheres: influence of plasticizer RATIO as pore-forming agent.Effect of additives on the release of a model protein from PLGA microspheres.Formulation and evaluation of mucoadhesive glipizide microspheres Galactomannan gum coated mucoadhesive microspheres of glipizide for treatment of type 2 diabetes mellitus: In vitro and in vivo evaluation.Alendronate PLGA microspheres with high loading efficiency for dental applications.

P2860

Q30847388-E059994C-4B30-4D43-A204-783073C79F19 Q35074310-F827A63F-05EF-479E-B801-E6B81FE6FA6B Q35100355-26D36CD3-227B-4FCE-976B-B4E3832AA5CE Q36882127-0FC7AB5A-EF7F-441B-BEAF-CE91F6CA4FC1 Q39422845-8EBECC79-7B21-4EBB-A66F-B6B826C27BF1 Q41811471-19A849DC-97B3-4D4D-98A5-12CBA9CD5414 Q41990304-19E7F109-688C-4342-A559-EF6D5AAB61CB Q42046044-1D6A7353-E776-418C-A5DB-A987A985E3CB Q46045226-B7BABDE6-314C-4F35-825D-2AB691637BAE

P2860

Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

http://www.wikidata.org/entity/Q41990628

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Effect of isopropyl myristic a ...... poside from PLGA microspheres.

@en

type

label

Effect of isopropyl myristic a ...... poside from PLGA microspheres.

@en

prefLabel

Effect of isopropyl myristic a ...... poside from PLGA microspheres.

@en

P1433

Q41990628-BB056928-11E2-4427-816C-4175B20C8FF1

P1476

Q41990628-1C1AF056-8954-44BF-882F-ADC200504DB5

P2093

Q41990628-C48D3531-38B1-4226-8EAA-991187DC892A

Q41990628-CB5ED649-B968-4C6D-A8BD-41BB914CF5FF

P2860

Q41990628-05CED153-37C7-4FE7-BCC1-BA2DBFB0D723

Q41990628-59AEF6D2-FF20-4021-ABE5-E1D0FD6784D1

Q41990628-72427E76-D095-4A1D-BF68-3F137EB12645

Q41990628-90010A09-B1D0-4003-8376-857746068A00

Q41990628-928591C5-7952-4B17-9CD6-BAB3C5B6697A

Q41990628-CCB64B01-753D-434C-A386-71066E3721BD

Q41990628-D23FB146-2F0C-4CA2-ABD6-C9FB84307BCC

Q41990628-D724E4D7-16DD-40DF-A089-F7DD1992DFB0

Q41990628-F15BDBF8-31A8-4A4E-96FF-99B443438377

P2888

Q41990628-1A1A0972-0C4C-432F-A41A-EB4FACFA9979

P304

Q41990628-E84D63F8-EAA3-40CD-8D8E-C0DB16D1CE47

P31

Q41990628-81105E74-D879-4DB9-BA03-89CD2C269FB4

P356

Q41990628-C1205356-E8D7-4148-B641-A53E5B6BDEF5

P407

Q41990628-8D0E325B-4F6A-43FD-BDD7-7576BA62A6F5

P433

Q41990628-00B3976F-BD86-4D4D-8CC2-D20EABC3FCF8

P478

Q41990628-C5AC083C-F7D0-4666-B634-676BC5E9CF79

P577

Q41990628-B413AC51-A08F-485B-B0DF-0E32CFD907D6

P5875

Q41990628-9A5FBD57-7A41-4E1B-BF4B-9CA889A8C8BA

P6179

Q41990628-ED6117C4-254C-445D-980A-25AF0FF2AA72

P698

Q41990628-A4D8ABAB-51BD-4FF1-ABC1-FD2AEA9D956C

P932

Q41990628-40956720-95BE-4F7C-9609-C78DFEC1C83C

P356

P1433

AAPS PharmSciTech

P1476

Effect of isopropyl myristic a ...... poside from PLGA microspheres.

@en

P2093

J Singh

http://www.w3.org/2001/XMLSchema#string

M J Schaefer

http://www.w3.org/2001/XMLSchema#string

P2860

Etoposide: four decades of development of a topoisomerase II inhibitor

A novel in vitro release technique for peptide containing biodegradable microspheres

Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant.

Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.

Etoposide (VP-16-213). Current status of an active anticancer drug.

Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy.

Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles.

Aminophylline targeting to lung: optimization of the size and drug loading of albumin microspheres.

P2888

P304

E32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/PT010432

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8915769

http://www.w3.org/2001/XMLSchema#string

P6179

1037855456

http://www.w3.org/2001/XMLSchema#string

P698

14727897

http://www.w3.org/2001/XMLSchema#string

P932

2750456

http://www.w3.org/2001/XMLSchema#string